Current Report Filing (8-k)
June 11 2019 - 04:49PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of
The
Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
June 5, 2019
MARIMED
INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
0-54433
|
|
27-4672745
|
(State
or other jurisdiction
|
|
(Commission
|
|
(IRS
Employer
|
of
incorporation)
|
|
File
Number)
|
|
Identification
No.)
|
10
Oceana Way, Norwood, Massachusetts
|
|
02062
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code:
(617) 795-5140
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act: None.
Title
of each class
|
|
Ticker
symbol(s)
|
|
Name
of each exchange on which registered
|
Not
Applicable.
|
|
Not
Applicable.
|
|
Not
Applicable.
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company [X]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item
5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
of Certain Officers.
On
June 5, 2019, the Registrant received a letter from Thomas Kidrin resigning from the Registrant’s board of directors, effective
immediately. The letter, a copy of which is filed as Exhibit 99.1 to this Current Report, states that Mr. Kidrin’s resignation
was “due to a dispute over outstanding matters.” No further explanation was provided.
As previously reported
in its Forms 10-K and 10-Q, the Registrant contends that an employment agreement with Mr. Kidrin is not valid. The
Registrant is currently evaluating commencement of legal action against Mr. Kidrin.
Item
9.01. Financial Statements and Exhibits.
(d)
Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
MARIMED
INC.
|
|
|
|
Dated:
June 11, 2019
|
|
|
|
By:
|
/s/
ROBERT FIREMAN
|
|
|
Robert
Fireman, CEO
|
EXHIBIT
INDEX
MariMed (QX) (USOTC:MRMD)
Historical Stock Chart
From Feb 2024 to Mar 2024
MariMed (QX) (USOTC:MRMD)
Historical Stock Chart
From Mar 2023 to Mar 2024